Related Experiment Video
Updated: Sep 11, 2025
09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
679
Tumor-Immune Cell Interactions in Cancer Progression.
Xiaoxue Zhou1,2, Feng Xie3, Long Zhang4,5,6
1MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, China.
Cancer Research
|August 15, 2025
Summary
Understanding the tumor microenvironment
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- The tumor microenvironment (TME) is a complex ecosystem crucial for cancer progression.
- Immune cell components within the TME significantly influence tumor initiation, metastasis, and patient prognosis.
- Aberrant immune responses in the TME necessitate a deeper understanding of tumor-immune interactions for effective cancer therapies.
Purpose of the Study:
- To review recent advancements in understanding tumor-immune interactions within the TME.
- To focus on intrinsic factors (cancer genetics, epigenetics) and extrinsic factors (metabolic reprogramming).
- To explore key mechanisms of tumor-immune cross-talk and propose future research directions.
Main Methods:
- Review of recent scientific literature on tumor-immune interactions.
- Analysis of intrinsic and extrinsic factors influencing the TME.
- Examination of communication mechanisms like exosomes, liquid-liquid phase separation, and circulating tumor cells.
Main Results:
- The TME's complexity involves intricate interactions between cancer cells and immune components.
- Intrinsic factors like genetics and epigenetics, alongside extrinsic factors such as metabolic reprogramming, critically shape tumor-immune dynamics.
- Mechanisms including exosome-mediated communication, liquid-liquid phase separation, and circulating tumor cells are key to tumor-immune cross-talk.
Conclusions:
- Elucidating tumor-immune interactions is vital for developing novel cancer therapies.
- Understanding the multifaceted TME can lead to improved strategies against cancer metastasis.
- Future research should focus on harnessing these interactions to enhance therapeutic efficacy.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
01:22T Cell Activation and Clonal Selection
4.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.6K
01:27Cytotoxic T Cells-mediated Immune Response
2.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.0K